Evaluation of immunotherapy and targeted therapy treatment on renal cell carcinoma: A Bayesian network analysis.
Ontology highlight
ABSTRACT: Clinical trials have previously assessed various therapies for renal cell carcinoma (RCC); however, there is currently a lack of direct comparisons between these therapies. The present study identified published studies on RCC through Web of Science, PubMed, EMBASE, Cochrane Library of Controlled Trials and Clinical trials.gov that were written in the English language and published by February 2019. The data were selected and extracted independently by two reviewers. Standard pair-wise meta-analyses were performed using Stata. Network meta-analyses were subsequently performed using WinBUGS (version 1.4.3). The primary outcome of the present study was progression-free survival (PFS). Secondary outcomes included overall survival (OS), objective response rate (ORR) and adverse events of vario
SUBMITTER: Wei W
PROVIDER: S-EPMC6924115 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA